You just read:

Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients

News provided by

ViaCyte, Inc.

Jan 21, 2019, 09:00 ET